Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives $56.08 Average Price Target from Brokerages
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have assigned a buy rating and one has […]
23 Aug 01:44 · The Cerbat Gem